Abstract:The transition of a healthy tissue to a pre-malignant and subsequent malignant stage is typically characterized by a marked increase in extracellular fibrosis and collagen density. Such changes coincide with a significant increase in tissue stiffness as the tumor progresses. Despite the large body of work on endothelial cell changes in tumoral angiogenesis, little is known about the dynamic interactions of endothelial cells, perivascular cells, and the extracellular matrix in early-to-late cancers. Appreciating such interactions is crucial for understanding tumorigenesis and early tumor progression. To model the spectrum of vascular changes occurring on pre-tumoral and tumoral ecosystems, we developed an organ-on-a-chip model of biomimetic pericyte-supported capillaries with collagen having increasingly higher density, stiffness and discrete fibril microarchitectures. Briefly, 160-um channels were engineered using type I collagen that underwent fibrillogenesis at different temperatures (4, 16, 21, and 37oC). Thus, the microarchitecture and stiffness would vary from a soft reticular network (healthy/pre-cancerous vascular capillaries) to a stiff fibrillar mesh (fibrotic/tumoral vascular capillaries). We then seeded human umbilical vein endothelial cells (HUVECs) and mesenchymal stem cells (MSCs) in the collagen channels. After 48h, samples were fixed and stained for actin (cytoskeleton), NG2 (pericyte differentiation), and CD31 (endothelial cell junction), laminin, and cell anchorage system, imaged with a confocal microscope and analyzed with Imaris. In addition, we used a Nanostring panel with 770 genes related to the tumor microenvironment in healthy and fibrosis. Vascular capillaries engineered in contact with softer reticular collagen, consistent with a healthy ECM, showed more pericyte differentiation (p<0.05), inter-endothelial cell junctions (p<0.05), and effective barrier function. In contrast, stiffer fibrillar collagen, which is consistent with the characteristics of the fibrotic malignant extracellular microenvironment, was associated with cell migration outward the vessel, leakiness, and higher RNA expression of interleukin 8 (IL8), TP53, transforming growth factor beta, vimentin, and collagen III genes, thus suggesting a system that compatible with the spectrum of tumoral vasculature changes in cancer and pre-cancer lesions. When vessels were engineered without MSCs, those differences were drastically minimized, To further understand the mechanisms, HUVEC-perivascular cell adhesion was disrupted using silencing RNA for NOTCH3. Upon silencing NOTCH3, the morphology and function of vasculature were reestablished, pointing to a major role of perivascular cells in vascular changes in early tumors. Funding: NIDCR 1K01DE030484-01A1 to CMF R01DE026170, 3R01DE026170-03S1 and 3R01DE026170-03S2 to LEB Citation Format: Cristiane Franca, Avathamsa Athirasala, Emilios Dimitriadis, Jennifer Bays, Kenneth Yamada, Christopher Chen, Luiz E. Bertassoni. Modeling the spectrum of vascular changes occurring in healthy and early malignant cancers on a chip [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6894.

Multiscale computational model predicts how environmental changes and drug treatments affect microvascular remodeling in fibrotic disease

Bioengineered in Vitro Tissue Model of Fibroblast Activation for Modeling Pulmonary Fibrosis

A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiology

Ex vivo modeling of human lung fibrogenesis and drug mode of action screens using single cell RNA-seq in precision-cut lung slices

Human Microvasculature-on-a Chip: Anti-Neovasculogenic Effect of Nintedanib in Vitro

Real‐Time Measurement of Cell Mechanics as a Clinically Relevant Readout of an In Vitro Lung Fibrosis Model Established on a Bioinspired Basement Membrane

A predictive multiscale model of in-stent restenosis in femoral arteries: linking haemodynamics and gene expression with an agent-based model of cellular dynamics

Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts

Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy

Abstract 6894: Modeling the spectrum of vascular changes occurring in healthy and early malignant cancers on a chip

Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease

The evolution of in vitro models of lung fibrosis: promising prospects for drug discovery

Multiscale single-cell assessment of the fibrotic niche in idiopathic pulmonary fibrosis

Variations in mechanical stiffness alter microvascular sprouting and stability in a PEG hydrogel model of idiopathic pulmonary fibrosis

Network modeling predicts personalized gene expression and drug responses in valve myofibroblasts cultured with patient sera

Microcomputed tomography visualization and quantitation of the pulmonary arterial microvascular tree in mouse models of chronic lung disease

Engineered cell and tissue models of pulmonary fibrosis.

Experimental Models to Study Endothelial to Mesenchymal Transition in Myocardial Fibrosis and Cardiovascular Diseases

Multiphase micro-computed tomography reconstructions provide dynamic respiratory function in a mouse lung fibrosis model

Micro-CT-assisted identification of the optimal time-window for antifibrotic treatment in a bleomycin mouse model of long-lasting pulmonary fibrosis

Dynamic multi-omics and mechanistic modeling approach uncovers novel mechanisms of kidney fibrosis progression